Archive for August, 2007

Proteros biostructures raises 5.2 Million Euros for Business Expansion

August 22 - Proteros biostructures GmbH, located in Martinsried, announced that the BayBG Bayerische Beteiligungsgesellschaft mbH in Munich has again invested, currently €1,000,000, in Proteros as a silent partner.

EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound

Aug. 17 — EpiCept Corporation today reported on new clinical advancements for Azixa (MPC-6827), a vascular disrupting agent licensed by the Company to Myriad Genetics, Inc. as part of an exclusive, worldwide development and commercialization agreement.

Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter

Aug. 16 :Advanced Life Sciences Holdings, Inc. , today announced that on August 13, 2007 the Nasdaq Listings Qualifications Department informed the Company that the market value of its listed securities was below $50 million for 10 consecutive days,

Susan G. Komen for the Cure, Elizabeth Edwards and Other Breast Cancer Survivors and Activists Call for Political Action to End Disease

Aug. 16 : Susan G. Komen for the Cure, Elizabeth Edwards and Iowa policymakers gathered with hundreds of community members, breast cancer survivors and activists at the Iowa State Fair today.

Nexgen Pharma, Inc. Announces Acquisition of Colorado Based Manufacturing Facility

Aug. 16 : Nexgen Pharma, Inc. announces that it has acquired certain assets of The Chemins Company, Inc. located in Colorado Springs, CO.

Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma

Aug. 15 : Millennium Pharmaceuticals, Inc. today announced the initiation of a randomized, multi-center, Company-sponsored Phase II trial to evaluate the efficacy of combining

BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance

Aug. 15 : BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that it has appointed Dr. Thaddeus Pullano, 53, as Vice President of Quality Assurance.

Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry

Aug. 14 : A new report ranks Ohio best in the Midwest for venture capital investments in biotech innovation and business growth, according to the Ohio Business Development Coalition (OBDC),

WuXi PharmaTech Announces Closing of Initial Public Offering

Aug. 14 : WuXi PharmaTech , the leading China-based pharmaceutical and biotechnology research and development outsourcing company in the growing global drug R&D outsourcing market,

Sigma-Aldrich Enters Distribution Agreement With CellPath to Serve UK Healthcare Market

Aug. 14 : Sigma-Aldrich , a leading $1.8 billion Life Science and High Technology company, has signed a national distribution agreement with CellPath, a leading distributor of healthcare products, to serve the healthcare market in the UK.